Close Menu

On the Wall Street Journal health blog, Jacob Goldstein discusses the "battle" for the diagnostic company Ventana -- Roche made a hostile bid for the company earlier this year. Goldstein reports that Roche's CEO, Franz Hume, has been saying that hedge funds have bought out the leading shareholders but that Roche's $3 billion offer will eventually go through.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New research shows that scientists need to do a better job of including a wider diversity of African genomes in their analyses, STAT says.

A new paper in Science shows that men are still winning a large majority of the most sought-after NIH grants.

Nature Research and the Estée Lauder Companies are awarding efforts to encourage girls to pursue careers in the STEM fields.

In Science this week: beneficial genetic variants inherited from archaic Neanderthal and Denisovan hominins, and more.